Trials / Unknown
UnknownNCT05944627
Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis
A Single, Dose Escalation, Optimal Dose Finding Phase I/IIa Clinical Trial to Evaluate Safety and Explore Efficacy of the Single Treatment of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 68 (estimated)
- Sponsor
- Kang Stem Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A Single, Dose Escalation, Optimal Dose Finding Phase I/IIa Clinical Trial to Evaluate Safety and Explore Efficacy of the Single Treatment of FURESTEM-OA Kit Inj. in Patients with Knee Osteoarthritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | FURESTEM-OA Kit Inj. | FURESTEM-OA Kit Inj. is a combination medical product in which FURESTEM-OA Inj. (solution 1) is the primary mode of action and CAM Inj. (solution 2) acts as an auxiliary. The product is administered after mixing solution 1 and solution 2. |
| BIOLOGICAL | Placebo | placebo administration in Phase 2a clinical trial |
Timeline
- Start date
- 2023-07-06
- Primary completion
- 2024-03-31
- Completion
- 2026-02-28
- First posted
- 2023-07-13
- Last updated
- 2023-07-14
Source: ClinicalTrials.gov record NCT05944627. Inclusion in this directory is not an endorsement.